3D Printing Technology in Personalized Drug Formulation and Pharmacy Practice

Authors

  • Nabila Salsabila Yusuf Research Center for Pharmaceutical Innovation and Additive Manufacturing, Bandung Institute of Technology, Indonesia
  • Muhammad Arslan Research Center for Pharmaceutical Innovation and Additive Manufacturing, Bandung Institute of Technology, Indonesia

DOI:

https://doi.org/10.37899/mjdh.v3i2.375

Keywords:

Additive Manufacturing, Digital Pharmacy, Personalized Medicine, Pharmaceutical Innovation, Pharmacy Practice, Precision Medicine

Abstract

This study examines the role of 3D printing technology in personalized drug formulation and pharmacy practice within the context of precision medicine and digital healthcare transformation. Using a systematic literature review approach based on the PRISMA framework, this research analyzed 52 peer-reviewed international journal articles related to pharmaceutical additive manufacturing. The findings indicate that 3D printing technology enhances dosage customization, controlled drug release, medication adherence, and patient-centered pharmaceutical care. The study also highlights the transformation of pharmacy practice from conventional dispensing services toward decentralized and digitally integrated pharmaceutical systems. Oharmacists are increasingly required to develop competencies in digital formulation design, artificial intelligence integration, and precision medicine applications. Despite its significant potential, several challenges remain, including regulatory uncertainty, infrastructure limitations, cybersecurity concerns, and limited professional readiness. The novelty of this study lies in its integrative perspective that combines pharmaceutical technology innovation, pharmacy practice transformation, and healthcare system adaptation within a unified analytical framework.

References

Ahmed, R., & Tamim, T. R. (2025). Enhancing medication safety: the role of community and hospital pharmacists in modern healthcare systems. Radinka Journal of Health Science, 2(3), 328-355. https://doi.org/10.56778/rjhs.v2i3.418

Algorri, M., Abernathy, M. J., Cauchon, N. S., Christian, T. R., Lamm, C. F., & Moore, C. M. (2022). Re-envisioning pharmaceutical manufacturing: increasing agility for global patient access. Journal of Pharmaceutical Sciences, 111(3), 593-607. https://doi.org/10.1016/j.xphs.2021.08.032

Alhozim, B. M. A., Almutairi, E. T., Albutyan, Z. Y., Alzahrani, N. A., Alonizy, M. M., Albutyan, L. Y., ... & ZALAH, F. A. B. (2024). The impact of polypharmacy on drug efficacy and safety in geriatric populations. Egyptian Journal of Chemistry, 67(13), 1533-1540. https://doi.org/10.21608/ejchem.2024.337875.10834

Ali Alasmari, A. F., Alqahtani, M. A., Abdullah, A. M., Nasir, M. A., & Almalki, A. H. (2024). Collaborative dynamics between nursing and pharmacists: Enhancing patient care through interdisciplinary practices. Modern Phytomorphology, 18(6).

Almusaed, A., Almssad, A., & Yitmen, I. (2025). Identifying Research Gaps. In Practice of Research Methodology in Civil Engineering and Architecture: A Comprehensive Guide (pp. 35-66). Cham: Springer Nature Switzerland. https://doi.org/10.1007/978-3-031-97393-2_2

Al-Worafi, Y. M. (2023). Medicine availability and affordability in developing countries. In Handbook of Medical and Health Sciences in Developing Countries: Education, Practice, and Research (pp. 1-29). Cham: Springer International Publishing. https://doi.org/10.1007/978-3-030-74786-2_229-1

Alzoubi, L., Aljabali, A. A., & Tambuwala, M. M. (2023). Empowering precision medicine: the impact of 3D printing on personalized therapeutic. Aaps Pharmscitech, 24(8), 228. https://doi.org/10.1208/s12249-023-02682-w

Andreadis, I. I., Gioumouxouzis, C. I., Eleftheriadis, G. K., & Fatouros, D. G. (2022). The advent of a new era in digital healthcare: a role for 3D printing technologies in drug manufacturing?. Pharmaceutics, 14(3), 609. https://doi.org/10.3390/pharmaceutics14030609

Balogun, O. D., Ayo-Farai, O., Ogundairo, O., Maduka, C. P., Okongwu, C. C., Babarinde, A. O., & Sodamade, O. T. (2023). Innovations in drug delivery systems: A review of the pharmacist's role in enhancing efficacy and patient compliance. World Journal of Advanced Research and Reviews, 20(3), 1268-1282. https://doi.org/10.30574/wjarr.2023.20.3.2587

Barar, J., Seamon, M., & Omidi, Y. (2026). The emergence of advanced technologies in the pharmacy profession and the need for education: The case of point-of-care sensing systems and 3D printing of pharmaceuticals. BioImpacts, 16(1), 31081-31081. https://doi.org/10.34172/bi.31081

Barar, J., Seamon, M., & Omidi, Y. (2026). The emergence of advanced technologies in the pharmacy profession and the need for education: The case of point-of-care sensing systems and 3D printing of pharmaceuticals. BioImpacts, 16(1), 31081-31081. https://doi.org/10.34172/bi.31081

Beridze, T., & Lomidze, G. (2025). The Strategic Application of Data Analytics in Developing Smarter Healthcare Systems: Enhancing Diagnostic Precision and Personalized Treatment Pathways. International Journal of Advanced Computational Methodologies and Emerging Technologies, 15(5), 1-10.

Bernatoniene, J., Stabrauskiene, J., Kazlauskaite, J. A., Bernatonyte, U., & Kopustinskiene, D. M. (2025). The future of medicine: how 3D printing is transforming pharmaceuticals. Pharmaceutics, 17(3), 390. https://doi.org/10.3390/pharmaceutics17030390

Borthakur, P. P., Das, A., Sahariah, J. J., Pramanik, P., Baruah, E., & Pathak, K. (2026). Revolutionizing patient care: 3D printing for customized medical devices and therapeutics. Biomedical Materials & Devices, 4(2), 1275-1302. https://doi.org/10.1007/s44174-025-00324-2

Comoglu, T., & Ozyilmaz, E. D. (2025). Pharmaceutical excipients in pediatric and geriatric drug formulations: safety, efficacy, and regulatory perspectives. Pharmaceutical Development and Technology, 30(1), 1-9. https://doi.org/10.1080/10837450.2024.2441181

Diaz, R. R., Satheesh, G., Moran, A. E., Perel, P., Rodgers, A., & Schutte, A. E. (2026). Delivery models to improve adherence to medicines for chronic diseases in primary care. The Lancet Primary Care, 2(1).

Gatt, E., Bartolo, N. S., & Azzopardi, L. A. (2026). systematic review of 3D Printing of pharmaceutical drug products: Barriers and Enablers. Available at SSRN 6571428. http://dx.doi.org/10.2139/ssrn.6571428

Geraghty, M., Malandrini, F., Callea, G., McDonnell, A., Martelli, N., Tangila Kayembe, O., ... & Melvin, T. (2026). Regulatory readiness for innovation: a mixed-methods study of national competent authority professional and organizational capacities in the context of pre-market clinical investigations and early feasibility studies. Expert Review of Medical Devices, (just-accepted). https://doi.org/10.1080/17434440.2025.2594460

Gioumouxouzis, C. I., Karavasili, C., & Fatouros, D. G. (2019). Recent advances in pharmaceutical dosage forms and devices using additive manufacturing technologies. Drug discovery today, 24(2), 636-643. https://doi.org/10.1016/j.drudis.2018.11.019

Hauber, B., Hand, M. V., Hancock, B. C., Zarrella, J., Harding, L., Ogden-Barker, M., ... & Watt, S. J. (2024). Patient acceptability and preferences for solid oral dosage form drug product attributes: a scoping review. Patient preference and adherence, 1281-1297. https://doi.org/10.2147/ppa.s443213

Huanbutta, K., Burapapadh, K., Sriamornsak, P., & Sangnim, T. (2023). Practical application of 3D printing for pharmaceuticals in hospitals and pharmacies. Pharmaceutics, 15(7), 1877. https://doi.org/10.3390/pharmaceutics15071877

Ilan, Y. (2022). Next-generation personalized medicine: implementation of variability patterns for overcoming drug resistance in chronic diseases. Journal of Personalized Medicine, 12(8), 1303. https://doi.org/10.3390/jpm12081303

Johannesson, J., Hansson, P., Bergström, C. A., & Paulsson, M. (2022). Manipulations and age-appropriateness of oral medications in pediatric oncology patients in Sweden: Need for personalized dosage forms. Biomedicine & Pharmacotherapy, 146, 112576. https://doi.org/10.1016/j.biopha.2021.112576

Karvannan, R. (2025). Advancing Hospital Pharmacy Automation: Impacts, Challenges, and Future Innovations in AI-Driven Medication Management. International Journal of Advanced Research in Computer Science & Technology (IJARCST), 8(3), 12207-12216. https://doi.org/10.15662/IJARCST.2025.0803010

Kumar Gupta, D., Ali, M. H., Ali, A., Jain, P., Anwer, M. K., Iqbal, Z., & Mirza, M. A. (2022). 3D printing technology in healthcare: applications, regulatory understanding, IP repository and clinical trial status. Journal of Drug Targeting, 30(2), 131-150. https://doi.org/10.1080/1061186x.2021.1935973

Kurien, R. A., Kannan, G., Thanawut, K., Suttiruengwong, S., & Sriamornsak, P. (2025). Building the next frontier: Artificial intelligence in 3D-printed medicines. Biomaterials Translational, 7(1), 55. https://doi.org/10.12336/bmt.25.00043

Li, C., Jiang, W., Shen, A., Li, Y., Wu, J., Tao, H., ... & Zhao, Z. (2025). International expert consensus on hospital intelligent pharmacy. Intelligent Pharmacy. https://doi.org/10.1016/j.ipha.2025.06.001

Malheiro, V., Duarte, J., Veiga, F., & Mascarenhas-Melo, F. (2023). Exploiting pharma 4.0 technologies in the non-biological complex drugs manufacturing: innovations and implications. Pharmaceutics, 15(11), 2545. https://doi.org/10.3390/pharmaceutics15112545

Muhindo, D., Elkanayati, R., Srinivasan, P., Repka, M. A., & Ashour, E. A. (2023). Recent advances in the applications of additive manufacturing (3D printing) in drug delivery: a comprehensive review. Aaps Pharmscitech, 24(2), 57. https://doi.org/10.1208/s12249-023-02524-9

Navaei, O. (2025). Personalized medicine: tailoring treatment plans based on genetic profile. Eurasian Journal of Chemical, Medicinal and Petroleum Research, 4(2), 129-151.

Niazi, S. K. (2025). Continuous manufacturing of recombinant drugs: comprehensive analysis of cost reduction strategies, regulatory pathways, and global implementation. Pharmaceuticals, 18(8), 1157. https://doi.org/10.3390/ph18081157

Pandey, A., & Gupta, S. P. (2024). Personalized Medicine:(A Comprehensive Review). Oriental Journal Of Chemistry, 40(4). https://dx.doi.org/10.13005/ojc/400403

Patel, H., Raje, V., Maczko, P., & Patel, K. (2024). Application of 3D printing technology for the development of dose adjustable geriatric and pediatric formulation of celecoxib. International Journal of Pharmaceutics, 655, 123941. https://doi.org/10.1016/j.ijpharm.2024.123941

Pethappachetty, P., Kumar, B., Govindaraj, A., Prakash, M., Kumari, B. V., Venkatesan, K. B., & Srinivasan, M. K. (2025). 3D Printing in Personalized Medicine: Revolutionizing Drug Delivery and Healthcare Applications. Biomedical Materials & Devices, 1-22.

Prajapati, B., Malviya, R., Patel, R. J., & Sundram, S. (Eds.). (2026). Personalized Medication for Pediatric and Geriatric Patients. CRC Press.

Salvador-Carulla, L., Woods, C., de Miquel, C., & Lukersmith, S. (2024). Adaptation of the technology readiness levels for impact assessment in implementation sciences: The TRL-IS checklist. Heliyon, 10(9). https://doi.org/10.1016/j.heliyon.2024.e29930

Serrano, D. R., Kara, A., Yuste, I., Luciano, F. C., Ongoren, B., Anaya, B. J., ... & Lalatsa, A. (2023). 3D printing technologies in personalized medicine, nanomedicines, and biopharmaceuticals. Pharmaceutics, 15(2), 313. https://doi.org/10.3390/pharmaceutics15020313

Tegegne, A. M., Ayenew, K. D., & Selam, M. N. (2024). Review on Recent Advance of 3DP‐Based Pediatric Drug Formulations. BioMed Research International, 2024(1), 4875984. https://doi.org/10.1155/2024/4875984

Wang, S., Chen, X., Han, X., Hong, X., Li, X., Zhang, H., ... & Zheng, A. (2023). A review of 3D printing technology in pharmaceutics: technology and applications, now and future. Pharmaceutics, 15(2), 416. https://doi.org/10.3390/pharmaceutics15020416

Zhang, J., Vo, A. Q., Feng, X., Bandari, S., & Repka, M. A. (2018). Pharmaceutical additive manufacturing: a novel tool for complex and personalized drug delivery systems. AAPS PharmSciTech, 19(8), 3388-3402. https://doi.org/10.1208/s12249-018-1097-x

Downloads

Published

2026-07-20